Privia Health Group, Inc. Liability for Future Policy Benefits, Period Expense (Income)
Privia Health Group, Inc. (PRVA) reported Liability for Future Policy Benefits, Period Expense (Income) of $500.48 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:LiabilityForFuturePolicyBenefitsPeriodExpense · last filed 2026-08-06
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2026-06-30 was $500.48M, a 23.27% increase year-over-year.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2026-03-31 was $475.12M, a 26.76% increase year-over-year.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2025-12-31 was $424.67M, a 20.25% increase year-over-year.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for the quarter ending 2025-09-30 was $455.21M, a 35.28% increase year-over-year.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2025 was $1.66B, a 24.63% increase from fiscal 2024.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2024 was $1.33B, a 2.62% increase from fiscal 2023.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2023 was $1.30B, a 23.55% increase from fiscal 2022.
- Privia Health Group, Inc. liability for future policy benefits, period expense (income) for fiscal 2022 was $1.05B, a 44.41% increase from fiscal 2021.
| Period end | Liability for Future Policy Benefits, Period Expense (Income) 3 month | Liability for Future Policy Benefits, Period Expense (Income) 6 month | Liability for Future Policy Benefits, Period Expense (Income) 9 month | Liability for Future Policy Benefits, Period Expense (Income) 12 month |
|---|---|---|---|---|
| 2026-06-30 | $500.48M 10-Q · filed 2026-08-06 | $975.60M 10-Q · filed 2026-08-06 | $1.40B derived: sum of 3 quarters · filed 2026-08-06 | $1.86B derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $475.12M 10-Q · filed 2026-05-07 | $899.79M derived: sum of 2 quarters · filed 2026-05-07 | $1.35B derived: sum of 3 quarters · filed 2026-05-07 | $1.76B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $424.67M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $879.88M derived: sum of 2 quarters · filed 2026-02-27 | $1.29B derived: sum of 3 quarters · filed 2026-08-06 | $1.66B 10-K · filed 2026-02-27 |
| 2025-09-30 | $455.21M 10-Q · filed 2025-11-06 | $861.20M derived: sum of 2 quarters · filed 2026-08-06 | $1.24B 10-Q · filed 2025-11-06 | $1.59B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $405.99M 10-Q · filed 2026-08-06 | $780.80M 10-Q · filed 2026-08-06 | $1.13B derived: sum of 3 quarters · filed 2026-08-06 | $1.47B derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $374.81M 10-Q · filed 2026-05-07 | $727.97M derived: sum of 2 quarters · filed 2026-05-07 | $1.06B derived: sum of 3 quarters · filed 2026-05-07 | $1.39B derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $353.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $689.66M derived: sum of 2 quarters · filed 2026-02-27 | $1.01B derived: sum of 3 quarters · filed 2026-02-27 | $1.33B 10-K · filed 2026-02-27 |
| 2024-09-30 | $336.50M 10-Q · filed 2025-11-06 | $659.04M derived: sum of 2 quarters · filed 2025-11-06 | $979.37M 10-Q · filed 2025-11-06 | $1.33B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | $322.54M 10-Q · filed 2025-08-07 | $642.87M 10-Q · filed 2025-08-07 | $992.25M derived: sum of 3 quarters · filed 2026-02-27 | $1.32B derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | $320.34M 10-Q · filed 2025-05-08 | $669.71M derived: sum of 2 quarters · filed 2026-02-27 | $994.94M derived: sum of 3 quarters · filed 2026-02-27 | $1.32B derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | $349.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $674.60M derived: sum of 2 quarters · filed 2026-02-27 | $996.32M derived: sum of 3 quarters · filed 2026-02-27 | $1.30B 10-K · filed 2026-02-27 |
| 2023-09-30 | $325.22M 10-Q · filed 2024-11-07 | $646.94M derived: sum of 2 quarters · filed 2024-11-07 | $949.20M 10-Q · filed 2024-11-07 | $1.23B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $321.72M 10-Q · filed 2024-08-08 | $623.97M 10-Q · filed 2024-08-08 | $908.34M derived: sum of 3 quarters · filed 2025-02-27 | $1.17B derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $302.25M 10-Q · filed 2024-05-09 | $586.62M derived: sum of 2 quarters · filed 2025-02-27 | $851.80M derived: sum of 3 quarters · filed 2025-02-27 | $1.11B derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $284.37M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $549.54M derived: sum of 2 quarters · filed 2025-02-27 | $808.85M derived: sum of 3 quarters · filed 2025-02-27 | $1.05B 10-K · filed 2025-02-27 |
| 2022-09-30 | $265.17M 10-Q · filed 2023-11-03 | $524.49M derived: sum of 2 quarters · filed 2023-11-03 | $766.67M 10-Q · filed 2023-11-03 | $973.39M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-06-30 | $259.31M 10-Q · filed 2023-08-03 | $501.50M 10-Q · filed 2023-08-03 | $708.22M derived: sum of 3 quarters · filed 2024-02-27 | $898.27M derived: sum of 4 quarters · filed 2024-02-27 |
| 2022-03-31 | $242.19M 10-Q · filed 2023-05-04 | $448.91M derived: sum of 2 quarters · filed 2024-02-27 | $638.96M derived: sum of 3 quarters · filed 2024-02-27 | $808.90M derived: sum of 4 quarters · filed 2024-02-27 |
| 2021-12-31 | $206.72M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-27 | $396.78M derived: sum of 2 quarters · filed 2024-02-27 | $566.71M derived: sum of 3 quarters · filed 2024-02-27 | $727.83M 10-K · filed 2024-02-27 |
| 2021-09-30 | $190.06M 10-Q · filed 2022-11-10 | $359.99M derived: sum of 2 quarters · filed 2022-11-10 | $521.11M 10-Q · filed 2022-11-10 | |
| 2021-06-30 | $169.94M 10-Q · filed 2022-08-11 | $331.05M 10-Q · filed 2022-08-11 | ||
| 2021-03-31 | $161.11M 10-Q · filed 2022-05-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Strata Critical Medical, Inc. (SRTA) | United States | $0.467B | 11.33 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B |